What is Fragment 176-191?
Fragment 176-191, also known as neuron cytoplasmic protein 9.5, Frag 176-191, or gracile axonal dystrophy, is a peptide that is a modified version of amino acids 176-191. Its molecular formula is C78H125N23O23S2, and it has a molecular weight of 1817.12. According to scientific study on animal test subjects, the peptide has been known to exhibit antibiotic tendencies, and has also demonstrated abilities that are consistent with antigen binders.
How Fragment 176-191 Works
According to scientific study that has been conducted on animal test subjects, it has been determined that Fragment 176-191 primarily works in two overarching functions:
- The stimulation of lipolysis – Lipolysis is the process that can be basically defined as the breakdown of fats. Studies have indicated that the peptide promotes a greater instance of this process to occur.
- The slowing down of lipogenesis – Lipogenesis is the process in which fatty acids that make up adipose tissue (also known as body fat) are formed. Studies have shown that Fragment 176-191 works to inhibit this process from occurring.
Scientific study based on animal test subjects has shown that the peptide can carry out these functions by essentially mimicking the process in which the regulation of fat metabolism is achieved. Further scientific study has indicated that Fragment 176-191 accomplishes this task without promoting any inadvertent negative effects on blood sugar or cellular proliferation. It can do this act of mimicry, in part, because its functionality enables it to engage the animal test subject on a deeply cellular level. Specifically, a level that chiefly involves two components of the cell: The cytoplasm and the endoplasmic reticulum membrane. These are in essence the parts of the cell that regulates cellular function and protein synthesis. Fragment 176-191 is able to replicate these functions, and this ultimately works to provide animal test subjects with a greater sense of homeostasis.
The result of this overarching process essentially allows an animal test subject to experience a more efficient means of weight loss. Studies have indicated that the presence of Fragment 176-191 allows for fat burning in the test subjects to occur at a rate that is 12.5 faster than it would otherwise occur. Additionally, these studies have determined that the presence of Fragment 176-191 can enable an animal test subject to experience an elevated level of fat oxidation, an increased measure of energy expenditure, and a boosted measure of muscle and tissue mass.
Fragment 176-191 and Brain Activity
Because of the way in which Fragment 176-191 functions – specifically, the way it has been shown to interact with the endoplasmic reticulum membrane – scientific study based on animal test subjects has determined that the preence of the peptide could play a key role in the concept of mental preservation. Specifically, it is thought that Fragment 176-191 could be considered a possible aid in brains that are afflicted with Parkinson’s disease and Alzheimer’s disease. The base of this theory is rooted in the fact that it has been demonstrated that brains suffering from either one of the diseases feature a down-regulated level of the peptide within their associated neuroendocrine systems.
Thus far, scientific study based on animal test subjects has determined that the presence of Fragment 176-191 may theoretically work to prevent the type of basal lesions that have been shown to be a key feature in the onset of Parkinson’s disease. Additionally, these studies have shown that Fragment 176-191’s functionality could work to offset the levels of toxicity and protein malfunction that play a prime role in the beginning stages of Alzheimer’s disease.
Fragment 176-191 and Insulin
Further scientific study based on animal test subjects has determined that the presence of Fragment 176-191 could play a vital role in insulin regulation. These studies indicated that the peptide has the faculty to boost the blood glucose levels within an animal test subject over a finite interval of time. These studies also show that the peptide can achieve a heightened level of insulin levels within plasma for a longer period of time. The reasoning behind this theory can be found within Fragment 176-191’s 15 amino acid structure, as it is thought that this particular sequence and the way in which it’s structured can shuttle insulin throughout an animal test subject’s body on a more regulated and more consistent basis.
Purely for Scientific Research
Despite the fact that there has been plenty of research on Fragment 176-191 in relation to how it functions and the benefits that can be derived from such functionality, it should be emphasized that the peptide is still just intended for scientific study at this point in time. All matters of research relating to the way in which Fragment 176-191 operates has been derived from scientific study on animal test subjects. Because of this, any findings or observations relating to Fragment 176-191’s overall functionality, mechanics, benefits, should exclusively be the product of study performed in a strictly contained environment such as a medical research facility or a laboratory.